状细胞癌在整个组织中的分子和细胞动态
Matthew R Kudelka1,2, Yonit Lavin1,2, Siman Sun1
1Howard Hughes Medical Institute, Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, The Rockefeller University, New York, New York 10065, USA.
Genes & development
|October 25, 2024
概括
状细胞癌 (SCC) 尽管起源不同,但具有共同的生物学途径. 了解癌症干细胞 (CSC) 及其免疫相互作用,揭示了SCC治疗的统一原则.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 状细胞癌 (SCC) 是源自各种上皮组织的常见癌症,对癌症发病率和死亡率有重大贡献.
- 尽管起源多样化,但越来越多的证据表明,共享的生物学途径是不同解剖部位SCC发展的基础.
研究的目的:
- 从各种解剖部位的SCC中比较共同点和差异,重点关注风险因素,遗传学和瘤发生驱动因素.
- 审查癌症干细胞 (CSCs) 在SCC启动,传播和治疗耐药性的作用.
- 突出从最近的分子和免疫学进展中出现的SCCs的统一原则.
主要方法:
- 文献综述综合了关于SCC风险因素,遗传学和分子程序的发现.
- 对癌症干细胞及其调控机制的研究分析.
- 检查CSC与免疫系统在SCC入侵和治疗耐药性方面的相互作用.
主要成果:
- 汇聚的证据表明,从皮肤,头部和部,肺部,食道和子宫到SCC之间有共同的生物学途径.
- 癌症干细胞 (CSCs) 对于SCC启动和传播至关重要,具有特定的基因和转化调节程序.
- CSCs与免疫系统之间的相互作用是SCCs入侵和治疗耐药性的关键决定因素.
结论:
- 基于分子技术和癌症干细胞研究的进步,正在出现了解SCC的统一原则.
- 基于这些共享的SCC途径,正在开发新的治疗范式,包括免疫疗法和向疗法.
- 更深入地了解CSC及其微环境对于克服状细胞癌的治疗耐药性至关重要.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Skin Cancer
3.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


